MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First Fully Synthetic Routes to… Jul 13, 2021
Will California Decriminalize Drugs? California Senator Previews Coming Psychedelics Bill Jun 27, 2021
MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board Jun 23, 2021
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19 Jun 22, 2021
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelic Jun 17, 2021
Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic Benchmark Data from COPE Program Jun 14, 2021
MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs Jun 10, 2021
